𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Production of human immunodeficiency virus by chronically infected cells grown in protein-free medium.

✍ Scribed by Claudia Pintér; Antonio G. Siccardi; Alberto Clivio


Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
431 KB
Volume
19
Category
Article
ISSN
1065-6995

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

A human T cell line chronically infected with Human Immunodeficiency Virus (HIV) has been adapted to grow in a chemically defined, protein‐free medium. Virus particles are produced at rates comparable to those of serum‐supplemented cultures; virus preparations free of undesirable proteins can be produced in preparative amounts by simple ultrafiltration procedures and cell culture supernatants can be used as such for the preparation of ELISA solid phases. This material has been used very conveniently for studies concerning characterization of antibodies against HlV‐specific proteins, interaction of HIV with complement components and inclusion of human cell‐derived proteins into virions; we propose its use as a powerful tool for the structural as well as functional analysis of the virus particle itself.


📜 SIMILAR VOLUMES


Infection of Epstein-Barr virus-transfor
✍ Anita De Rossi; Silvio Roncella; Maria Luisa Calabro; Emma D'Andrea; Marcella Pa 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 993 KB

## Abstract Four Epstein‐Barr virus‐positive lymphoblastoid cell lines (LCL) were successfully infected __in vitro__ with immunodeficiency virus type 1 (HIV‐1) as demonstrated by reverse transcriptase activity and p24 HIV antigen in culture supernatants, positive cell staining for gag‐encoded HIV p

Inhibition of leukocyte migration in aga
✍ A. W. Boddie Jr.; Marshall M. Urist; Darwin O. Chee; E. Carmack Holmes; Donald L 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 French ⚖ 533 KB

## Abstract KCl extracts of Melanoma 14, a human melanoma cell line grown in chemically defined serum‐free medium, inhibited leukocyte migration in 19/36 (53%) patients with malignant melanoma. Only 4/23 (17%) controls with non‐melanoma malignancies and 4/28 (14%) normal subjects with no history of